Opportunity Information: Apply for W81XWH 14 PRORP CTA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Peer Reviewed Orthopaedic Clinical Trial Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Apr 30, 2014 and posted on Apr 30, 2014.
  • Applicants must submit their applications by Oct 24, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $8,000,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 14 PRORP CTA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Peer Reviewed Orthopaedic Clinical Trial Award (PRORP CTA) is a U.S. Department of Defense funding opportunity run through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Congressionally Directed Medical Research Programs (CDMRP) umbrella. Its purpose is to fund the rapid launch and execution of clinical trials that can meaningfully improve outcomes for people with orthopaedic injuries that are relevant to military service. The program is specifically oriented toward problems seen after combat-related trauma, as well as non-battle orthopaedic injuries that still undermine unit readiness and slow or prevent return to duty or return to work. In practice, this means the award is looking for studies that can move quickly into patient-facing evaluation and produce evidence that can change clinical practice, rehabilitation pathways, or device and treatment decisions for Service Members and Veterans.

The award supports clinical trials that test interventions with real-world potential, including new products and approaches as well as more established interventions being evaluated in a rigorous way. Proposed trials may evaluate pharmacologic agents (including drugs and biologics), medical devices, clinical guidance or care pathways, and emerging technologies or technology-enabled approaches. A central requirement is that every application clearly explains why the work matters to military and/or Veteran populations affected by orthopaedic injury. The program also encourages collaboration with military researchers and clinicians, reflecting a preference for trials that are positioned to translate into military treatment facilities, VA-connected care environments, or other settings where Service Members and Veterans receive care.

Priority during review is higher for studies that include active-duty military members or Veterans as study participants, whether that population makes up the entire cohort or a defined subset. This is important because the program is not simply interested in general orthopaedic innovation; it is interested in evidence that is directly applicable to the unique injuries, occupational demands, and recovery expectations common in military contexts. Trials that can credibly show they will improve readiness metrics, accelerate functional recovery, or reduce long-term disability burden are aligned with the intent of the award.

The solicitation identifies several focus areas that reflect current gaps in orthopaedic trauma care and rehabilitation for military-relevant injuries. One focus area is identifying and reducing secondary health effects that follow reduced mobility after traumatic neuromusculoskeletal injury. Examples given include joint contracture, obesity, metabolic syndrome, and poor bone health, all of which can compound disability and make full recovery harder even after the initial injury is treated. Another area targets strategies to inhibit neuromas at surgical or amputation sites, a major contributor to residual limb pain, prosthetic intolerance, and reduced function. The announcement also highlights the development of prosthetic and orthotic devices through novel or innovative technologies and materials, indicating interest in next-generation components, improved interfaces, durability, comfort, and functionality that better match military and Veteran needs.

Additional emphasis areas include research toward osseointegration for upper extremity prostheses, signaling interest in trials that evaluate bone-anchored prosthetic attachment approaches and their impact on function, comfort, and complication rates. The program also calls for research on treatment of non-battle orthopaedic injuries that significantly impact unit readiness, especially those with historically poor return-to-work outcomes (less than 50 percent) or prolonged timelines (longer than 6 months). This focus recognizes that training injuries and other non-combat musculoskeletal problems can create substantial readiness losses and long-term costs. The solicitation further invites physical therapy and occupational therapy interventions designed to establish optimal rehabilitation and compare the effectiveness of different PT/OT regimens, which supports head-to-head testing of rehabilitation strategies rather than relying on tradition or local practice patterns. Finally, it includes clinical trials to restore function after volumetric muscle loss, a severe and challenging condition often associated with traumatic injuries where standard reconstruction may not fully restore strength and performance.

From an administrative standpoint, this opportunity (Funding Opportunity Number W81XWH-14-PRORP-CTA) was offered as a discretionary federal award using either a cooperative agreement or a grant mechanism. The CFDA program number is 12.420 (Military Medical Research and Development). The total estimated funding for the solicitation was $8,000,000, with an expected two awards, and there was no cost-sharing or matching requirement. Eligibility was listed as unrestricted, meaning it was broadly open to applicants (subject to any clarifications in the full announcement). Key dates in the posted record indicate it was posted on April 30, 2014, with an original and current closing date of October 24, 2014, and an archive date of November 23, 2014.

For support accessing the full announcement or troubleshooting submission systems, the notice points applicants to the CDMRP help desk (help@eBRAP.org) and a phone contact (301-682-5507), consistent with CDMRP submissions often being managed through the eBRAP platform.

FAQs: DoD Peer Reviewed Orthopaedic Clinical Trial Award (PRORP CTA)

What is the PRORP Clinical Trial Award (CTA)?

The DoD Peer Reviewed Orthopaedic Clinical Trial Award (PRORP CTA) is a U.S. Department of Defense funding opportunity under the Congressionally Directed Medical Research Programs (CDMRP). It is administered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA).

What is the main purpose of this award?

The purpose is to support the rapid launch and execution of clinical trials that can meaningfully improve outcomes for people with orthopaedic injuries relevant to military service. The intent is to generate evidence that can influence clinical practice, rehabilitation pathways, and device or treatment decisions for Service Members and Veterans.

What kinds of orthopaedic problems is the program focused on?

The program is oriented toward problems seen after combat-related trauma and non-battle orthopaedic injuries that still undermine unit readiness and can delay or prevent return to duty, return to work, or functional recovery.

Is this opportunity specifically for clinical trials?

Yes. The award is described as supporting clinical trials that can move quickly into patient-facing evaluation and produce actionable evidence.

What types of interventions can a proposed clinical trial evaluate?

Proposed trials may evaluate pharmacologic agents (including drugs and biologics), medical devices, clinical guidance or care pathways, and emerging technologies or technology-enabled approaches.

Does the application need to address military relevance?

Yes. A central requirement is that every application clearly explains why the work matters to military and/or Veteran populations affected by orthopaedic injury.

Is collaboration with military researchers or clinicians expected?

The program encourages collaboration with military researchers and clinicians and reflects a preference for trials positioned to translate into military treatment facilities, VA-connected care environments, or other settings where Service Members and Veterans receive care.

Are studies involving Service Members or Veterans prioritized?

Yes. Review priority is higher for studies that include active-duty military members or Veterans as study participants, either as the full study cohort or as a defined subset.

What kinds of outcomes are especially aligned with the intent of the award?

Trials that can credibly show they will improve readiness metrics, accelerate functional recovery, or reduce long-term disability burden are aligned with the stated intent.

What are the focus areas named in the solicitation?

The solicitation identifies multiple focus areas, including:

  • Identifying and reducing secondary health effects that follow reduced mobility after traumatic neuromusculoskeletal injury (examples include joint contracture, obesity, metabolic syndrome, and poor bone health)
  • Strategies to inhibit neuromas at surgical or amputation sites (to address residual limb pain, prosthetic intolerance, and reduced function)
  • Development of prosthetic and orthotic devices through novel or innovative technologies and materials (including improved interfaces, durability, comfort, and functionality)
  • Research toward osseointegration for upper extremity prostheses (bone-anchored attachment approaches and impacts on function, comfort, and complications)
  • Treatment of non-battle orthopaedic injuries that significantly impact unit readiness, especially those with historically poor return-to-work outcomes (less than 50 percent) or prolonged timelines (longer than 6 months)
  • Physical therapy and occupational therapy interventions to establish optimal rehabilitation and compare effectiveness of different PT/OT regimens
  • Clinical trials to restore function after volumetric muscle loss

What does the program mean by secondary health effects after reduced mobility?

The solicitation highlights that reduced mobility after traumatic neuromusculoskeletal injury can lead to additional health problems that compound disability. Examples provided include joint contracture, obesity, metabolic syndrome, and poor bone health.

Why are neuromas specifically mentioned?

The notice identifies neuromas at surgical or amputation sites as a major contributor to residual limb pain, prosthetic intolerance, and reduced function, making them a targeted area for intervention-focused clinical trials.

Is prosthetics and orthotics development within scope?

Yes. The solicitation explicitly highlights development of prosthetic and orthotic devices through novel or innovative technologies and materials, with interest in improvements that better match military and Veteran needs.

Does the opportunity mention osseointegration?

Yes. It calls for research toward osseointegration for upper extremity prostheses, including clinical trial evaluation of bone-anchored attachment approaches and their impact on outcomes such as function, comfort, and complication rates.

Are non-combat musculoskeletal injuries considered relevant?

Yes. The program explicitly includes non-battle orthopaedic injuries that undermine unit readiness and slow or prevent return to duty or work, with special emphasis on injuries with poor return-to-work outcomes or prolonged recovery timelines.

Are PT/OT rehabilitation trials encouraged?

Yes. The solicitation invites physical therapy and occupational therapy interventions designed to establish optimal rehabilitation and compare the effectiveness of different PT/OT regimens.

Is volumetric muscle loss included in the scope?

Yes. The solicitation includes clinical trials intended to restore function after volumetric muscle loss.

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number listed is W81XWH-14-PRORP-CTA.

What type of federal award mechanism is used?

The opportunity was offered as a discretionary federal award using either a cooperative agreement or a grant mechanism.

What is the CFDA program number for this opportunity?

The CFDA program number is 12.420 (Military Medical Research and Development).

How much total funding was estimated for the solicitation?

The total estimated funding was $8,000,000.

How many awards were expected?

The solicitation indicated an expectation of two awards.

Is cost sharing or matching required?

No. The notice states there was no cost-sharing or matching requirement.

Who is eligible to apply?

Eligibility was listed as unrestricted, meaning it was broadly open to applicants (subject to any clarifications in the full announcement).

What were the key dates for this opportunity?

The posted record indicates it was posted on April 30, 2014, with an original and current closing date of October 24, 2014, and an archive date of November 23, 2014.

Where can applicants get help accessing the full announcement or resolving submission issues?

The notice points applicants to the CDMRP help desk at help@eBRAP.org and a phone contact at 301-682-5507 for support with accessing the full announcement or troubleshooting submission systems (often managed through eBRAP).

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Peer Reviewed Orthopaedic Clinical Trial Development Award

Previous opportunity: DoD Peer Reviewed Orthopaedic Outcomes Research Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 14 PRORP CTA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 14 PRORP CTA) also looked into and applied for these:

Funding Opportunity
DoD Peer Reviewed Orthopaedic Clinical Trial Development Award Apply for W81XWH 14 PRORP CTDA

Funding Number: W81XWH 14 PRORP CTDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Peer Reviewed Orthopaedic Idea Development Award Apply for W81XWH 14 PRORP IDA

Funding Number: W81XWH 14 PRORP IDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Peer Reviewed Orthopaedic Translational Research Award Apply for W81XWH 14 PRORP TRA

Funding Number: W81XWH 14 PRORP TRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Wireless Innovation between Finland and the US Apply for 14 563

Funding Number: 14 563
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Biological Technologies Apply for DARPA BAA 14 38

Funding Number: DARPA BAA 14 38
Agency: Defense Advanced Research Projects Agency
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Centers of Excellence Autonomy, Cyber Security, and Research Data Analysis at Historically Black Colleges and Universities and Other Minority Serving Institutions of Higher Education Apply for BAA RIK 2014 0008

Funding Number: BAA RIK 2014 0008
Agency: Air Force Research Lab
Category: Science and Technology and other Research and Development
Funding Amount: $5,000,000
ROSES 2014 Heliophysics Infrastructure and Data Environment Enhancements Apply for NNH14ZDA001N HIDEE

Funding Number: NNH14ZDA001N HIDEE
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2014 WFIRST Preparatory Science Apply for NNH14ZDA001N WPS

Funding Number: NNH14ZDA001N WPS
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Gulf Coast CESU Apply for G14AS00067

Funding Number: G14AS00067
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
FY14 ACQUISITION RESEARCH PROGRAM Apply for NPS BAA 14 002

Funding Number: NPS BAA 14 002
Agency: Naval Supply Systems Command
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DHS ST COE Continuation Application Apply for DHS 14 061 COE NC001

Funding Number: DHS 14 061 COE NC001
Agency: Office of Procurement Operations Grants Division
Category: Science and Technology and other Research and Development
Funding Amount: $29,000,000
DoD Prostate Cancer Synergistic Idea Development Award Apply for W81XWH 14 PCRP SIDA

Funding Number: W81XWH 14 PCRP SIDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Idea Development Award Apply for W81XWH 14 PCRP IDA

Funding Number: W81XWH 14 PCRP IDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Compact High Density Tactical Energy Storage Apply for 14 SN 0012

Funding Number: 14 SN 0012
Agency: Office of Naval Research
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Gulf War Illness New Investigator Award Apply for W81XWH 14 GWIRP NIA

Funding Number: W81XWH 14 GWIRP NIA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
FY15 PROJECT ON ADVANCED SYSTEMS AND CONCEPTS FOR COUNTERING WMD (PASCC) Apply for NPS BAA 14 003

Funding Number: NPS BAA 14 003
Agency: Naval Supply Systems Command
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2014 Mars Data Analysis Program Apply for NNH14ZDA001N MDAP

Funding Number: NNH14ZDA001N MDAP
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Domestic Nuclear Detection Office Academic Research Initiative (ARI) Apply for DHS 14 DN 077 ARI 001

Funding Number: DHS 14 DN 077 ARI 001
Agency: Office of Procurement Operations Grants Division
Category: Science and Technology and other Research and Development
Funding Amount: $350,000
ROSES 2014 Lunar Data Analysis Program Apply for NNH14ZDA001N LDAP

Funding Number: NNH14ZDA001N LDAP
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
JFSP Primary Announcement (1 Task Statement) Apply for FA FON0014 0005

Funding Number: FA FON0014 0005
Agency: Bureau of Land Management
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 14 PRORP CTA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.